The Université de Lyon proposes in the section “Doctorat”, the setting up of a new system initiated by the Department of Doctoral Studies at the University of Lyon, with the expertise of OPE (Objective for Employment), ” From Doctorate to Employment “.
It is presented in the form of a six-month program led by experts, for the support of doctors tailored to the search for a permanent job outside the academic sector. This course is based on a collective dynamic led by professional trainers, and associated with a personalized accompaniment adapted to their profile.
The program of the device, with the contacts to be taken, is
These scientific days are an unmissible annual meeting for the laboratory. They are an excellent opportunity for the PhD students to present their angoing research (oral presentations and poster sessions) to the laboratory staff and partners. They will take place on June 22nd and 23rd, 2017 at Petit-Amphi of CPE Lyon. Event not to be missed !
Scientific program HERE
Isabelle Pitault (firstname.lastname@example.org)
Noureddine Lebaz (email@example.com)
LAGEP is member of Carnot institut since 2011.
Prof Ana Grenha from the University of Algarve (Portugal) will present a lecture.
The title is: “Inhalable dry powders for pulmonar tuberculosis therapy”
The conference will take place at Salle Bordet the 21st of June from 9h30 to 10h30.
Attached a short biography of Prof Ana Grenha
Ana Grenha has graduated in Pharmacy at Instituto Politécnico do Porto in 2001 and concluded her PhD in Pharmaceutical Technology in 2007, at the University of Santiago de Compostela, developing a Thesis on Nanomedicines applied to systemic pulmonary administration.
Ana Grenha is currently Assistant Professor of Pharmaceutical Technology at the Department of Chemistry and Pharmacy of the University of Algarve, since 2007. Being member of both the Centre for Biomedical Research (CBMR) and the Centre for Marine Sciences (CCMar), both of the University of Algarve, she is the Group Leader of the Drug Delivery Laboratory, which mainly develops research in the area of lung delivery. Ana Grenha has authored more than 40 papers/book chapters and 1 international patent, also having experience as Section Editor and Guest Editor in International Journals. In addition, she has supervised 9 Master Students and is the supervisor of 4 PhD students.
THE REGIONAL DAY OF THERAPEUTIC INNOVATIONS: ADVANCES AND PERSPECTIVES will take place on January 25, 2017 at the FACULTY OF PHARMACY, Hall of the Hermann Conferences (Level 1),
8 Avenue Rockefeller 69008 LYON.
The program is here !!
We congratulate Hatem Fessi, one of the most Highly cited researchers in the Thomson Reuters ranking:
Mr. MARZOUGUI Zied will present his work titled:
“Development of Functionalized Magnetic Latex for the Treatment of Wastewater by Adsorption”.
On December 16, 2016-12-02 at 2 pm in the Visioconference room (Bat.
Composition of the jury: strong>
M. Serge Stoll, maitre d’enseignement et de recherche ; Université de Genève
M. Moncef Msadek, Professeur des Universités ; Université de Monastir – FSM
Mme. Stéphanie Briancon, Professeur des Universités Université Claude Bernard Lyon 1
Mme. Emmanuelle Laurenceau, maitre de conférence ; Université Savoie Mont Blanc
M. Lassaâd Ben Mansour, Professeur des Universités ; Université de Sfax – FSS.
M. Boubaker ELLEUCH, Professeur des Universités ; Université de Sfax – ENIS.
M. Abedelhamid ELAISSARI, Direteur de Recherche ; Université Claude Bernard Lyon 1
Mme. Amel Chaabouni, Maitre assistante HDR ; Université de Sfax– FSS.
Professor Katrien Remaut (Laboratory for General Biochemistry and Physical Pharmacy) Ghent University, Belgium will give a lecture:
Monday, December 5 at 3:00 pm at the LAGEP, Salle Jacques Bordet
Prof. Katrien Remaut
Laboratory for General Biochemistry and Physical Pharmacy
Title of the presentation:
Stability measurements of nucleic acids or chemotherapeutics containing nanomedicines in biofluids by advanced microscopy methods
Katrien Remaut was born on the 10th of November 1978 in Ghent. In 2001, she graduated as Pharmacist with the greatest distinction. She then started research work in the Lab of General Biochemistry and Physical Pharmacy under guidance of Prof. De Smedt and Prof. Demeester.
In 2007, she received the title of doctor in pharmaceutical sciences with her dissertation ‘Exploring the relation between the intracellular fate and biological activity of nucleic acid nanoparticles’ and continued research work in the lab as postdoctoral fellow of the Research Foundation Flanders.
In 2009, Katrien joined the Directors Research Lab under guidance of Prof. Ian Mattaj at the European Molecular Biology Laboratory during 6 months.
Katrien is author and co-author of several peer reviewed scientific publication in e.g. Advanced Drug Delivery Reviews, Biochemistry-US, Biomacromolecules, Biophysical Journal, Journal of Controlled Release, ASC Nano, Nanomedicine and Macromolecules. She received several scientific prices (the scientific price ‘Bank van Breda’ in 2001; the Highlights of student posters Award in 2003; winner of the AIO competition in 2004; Jan Feijen Poster Award in 2010 and Price of the Royal Academy of Medicine for Scientific Research in Pharmacy, period 2008 – 2011). In 2013, Katrien was elected as member of the Young Academy in Flanders. She was appointed tenure track professor at the Lab General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences in 2014.
Le Professeur Vincenzo Bronte, Vnetian Institute of Molecular Medicine, Italy will make a conference:
Wednesday 7th December at 3pm at ISPB 7th of December 3pm, ISPB, 8 avenue Rockefeller, 69373 LYON CEDEX 08, Mediathèque Paul Zech.
Title of the presentation:
Myeloid-derived suppressor cells in cancers
Vincenzo Bronte is currently Head of the Immunology Section in the Department of Pathology and Diagnostics of Verona University. He is full professor of Immunology in Verona University.
Prof. Bronte was awarded in 2007 by the Accademia Nazionale dei Lincei (Rome, Italy) in 2008 by the Italian Foundation for Cancer Research for his oncology researchers. Prof. Bronte’s major achievements is the definition and molecular characterization of immunoregulatory cells, now called myeloid-derived suppressor cells (MDSCs), whose negative influence on antitumor immunity represents an obstacle to a successful immunotherapy of cancer. Current projects in the laboratory are further exploring the interplay between transformed cells and the surrounding stroma.